CARTXpress Bio

CARTXpress Bio, Inc., a subsidiary of ThermoGenesis Holdings, is a biotechnology company specializing in automated medical devices and technologies for cell-based therapies. The company's flagship product is the CAR-TXpress™ platform, a semi-automated, functionally closed system designed to streamline the manufacturing of chimeric antigen receptor (CAR) T cells and other immunotherapies. Utilizing patented buoyancy-activated cell separation (BACS) technology, the platform integrates cell isolation, selection, and washing into a single efficient workflow. CARTXpress Bio targets applications in stem cell banking, point-of-care treatments, and large-scale manufacturing for regenerative medicine and oncology. Headquartered in Rancho Cordova, California, the company provides critical infrastructure for the rapidly growing cell therapy industry.